Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 May;31(3):799-804.
doi: 10.1111/jvim.14694. Epub 2017 Mar 30.

Plasma Symmetric Dimethylarginine Concentration in Dogs with Acute Kidney Injury and Chronic Kidney Disease

Affiliations

Plasma Symmetric Dimethylarginine Concentration in Dogs with Acute Kidney Injury and Chronic Kidney Disease

D P Dahlem et al. J Vet Intern Med. 2017 May.

Abstract

Background: Symmetric dimethylarginine (SDMA) is considered a biomarker for early detection of renal dysfunction in human patients with acute kidney injury (AKI). At present, no studies exist analyzing the relevance of SDMA in dogs with AKI.

Hypothesis/objectives: SDMA would correctly identify dogs with renal disease but would not be able to differentiate between AKI and CKD.

Animals: Eighteen healthy control dogs, 48 dogs with AKI, and 29 dogs with CKD.

Methods: Prospective study. Dogs with kidney disease were categorized as having AKI or CKD according to the history, clinical signs, laboratory findings, and results of diagnostic imaging. Plasma SDMA concentration was measured by IDEXX Laboratories. SDMA/creatinine ratio was calculated in dogs with AKI or CKD.

Results: Median SDMA concentrations were 8.5 μg/dL (6-12 μg/dL), 39.5 μg/dL (8->100 μg/dL), and 35 μg/dL (12->100 μg/dL), in healthy, AKI, and CKD, respectively. SDMA concentrations were significantly higher in dogs with AKI (P < .0001) or CKD (P < .0001) in comparison with healthy dogs. Median SDMA/creatinine ratio in dogs with AKI and CKD was 6.5 (1.7-20.9) and 10 (2.4-33.9) (P = .0004), respectively. Although there was overlap of the SDMA/creatinine ratio in dogs with AKI or CKD, it was significantly higher in dogs with CKD compared to dogs with AKI (P = .0004).

Conclusions and clinical importance: In this population, SDMA was suitable for identifying dogs affected by AKI or CKD, but could not differentiate between them.

Keywords: Azotemia; Methylated arginines; Renal biomarker; Renal function.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Symmetric dimethylarginine (SDMA) concentration in healthy dogs, dogs with acute kidney injury (AKI), and dogs with chronic kidney disease (CKD). Lines represent median and 25th–75th percentile.
Figure 2
Figure 2
Creatinine and symmetric dimethylarginine (SDMA) in healthy dogs and dogs with acute kidney injury (AKI) or chronic kidney disease (CKD).
Figure 3
Figure 3
Symmetric dimethylarginine (SDMA) to creatinine ratio in dogs with acute kidney injury (AKI) and chronic kidney disease (CKD). Lines represent median and 25th–75th percentile.

Similar articles

Cited by

References

    1. Langston C. Acute uremia In: Ettinger SJ, Feldman EC, eds. Textbook of Veterinary Internal Medicine: Diseases of the Dog and the Cat, 7th ed St. Louis, MO: Saunders Elsevier; 2010:1969–1984.
    1. Harison E, Langston C, Palma D, Lamb K. Acute azotemia as a predictor of mortality in dogs and cats. J Vet Intern Med 2012;26:1093–1098. - PubMed
    1. Vaden SL, Levine J, Breitschwerdt EB. A retrospective case‐control of acute renal failure in 99 dogs. J Vet Intern Med 1997;11:58–64. - PubMed
    1. Thoen ME, Kerl ME. Characterization of acute kidney injury in hospitalized dogs and evaluation of a veterinary acute kidney injury staging system. J Vet Emerg Crit Care 2011;21:648–657. - PubMed
    1. Gerber B, Glaus TM, Unterer S, Reusch CE. Beurteilung von Parametern zur Unterscheidung von akuter und chronischer Niereninsuffizienz beim Hund. Schweiz Arch Tierheilk 2004;146:365–373. - PubMed